Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration

American Journal of Alzheimer's Disease and other Dementias

Volumn 17, Issue 5, 2002, Pages 267-272

  Chow, Tiffany W ^a   Mendez, Mario F ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Donepezil; Frontotemporal dementia; Paroxetine; Pharmacotherapy; Quetiapine; Valproic acid

Indexed keywords

AMANTADINE; AMFEBUTAMONE; BUSPIRONE; CARBIDOPA; CLOMIPRAMINE; DONEPEZIL; FLUOXETINE; LEVODOPA; LORAZEPAM; MIRTAZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID;

ADULT; AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY NEUROSIS; APHASIA; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DRUG INDICATION; DRUG TOLERABILITY; FEMALE; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERHIDROSIS; LIVEDO RETICULARIS; MALE; NIGHTMARE; OBSESSION; PARKINSONISM; PRACTICE GUIDELINE; SIDE EFFECT; SOMNOLENCE; STOMACH DISEASE; SYMPTOMATOLOGY; TREATMENT PLANNING;

EID: 0036750537     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/153331750201700504     Document Type: Article

References (24)

1. Mendez MF, Chow T, Ringman J, et al.: Pedophilia and temporal lobe disturbances. J Neuropsychiatry Clin Neurosci. 2000; 12: 71-76.
2. Mendez MF, Perryman KM, Miller BL, et al.: Compulsive behaviors as presenting symptoms of frontotemporal dementia. J Geriatr Psychiatry Neurol. 1997; 10: 154-157.
3. Mendez MF, Selwood A, Mastri AR, et al.: Pick's disease versus Alzheimer's disease: Comparison of clinical characteristics. Neurology. 1993; 43: 289-292.
4. Levy M, Miller BL, Cummings JL, et al.: Alzheimer's disease and frontotemporal dementias: Behavioral distinctions. Arch Neurol. 1996; 53: 687-690.
5. Snowden JS, Neary D: Neuropsychiatric aspects of frontotemporal dementias. Curr Psychiatry Rep. 1999; 1: 93-98.
6. Chow TW, Miller BL, Boone K, et al.: Frontotemporal dementia classification and neuropsychiatry. Neurologist. 2002; 8: 263-269.
7. Neary D, Snowden JS, Gustafson L, et al.: Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-1554.
8. Edwards-Lee T, Miller BL, Benson DF, et al.: The temporal variant of frontotemporal dementia. Brain. 1997; 120: 1027-1040.
9. Gregory CA, Hodges JR: Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm. 1996; 47: 103-123.
10. Miller BL, Darby A, Benson DF, et al.: Aggressive, socially disruptive, and antisocial behavior associated with frontotemporal dementia. Br J Psychiatr. 1997; 170: 150-155.
11. Silverman DH, Small GW, Chang CY, et al.: Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA. 2001;286:2120-2127.
12. Cummings JL, Mega M, Gray K, et al.: The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
13. Chouinard G, Saxena B, Belanger MC, et al.: A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder. J Affect Disord. 1999; 54: 39-48.
14. Francis PT, Holmes C, Webster MT, et al.: Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy. Dementia. 1993; 4: 72-79.
15. Sparks DL, Markesbery WR: Altered serotonergic and cholinergic synaptic markers in Pick's disease. Arch Neurol. 1991; 48: 796-799.
16. Sjogren M, Minthon L, Passant U, et al.: Decreased monoamine metabolites in frontotemporal dementia and Alzheimer's disease. Neurobiol Aging. 1998; 19: 379-384.
17. Swartz R, Miller BL, Lesser IM, et al.: Behavioral phenomenology in Alzheimer's disease, frontotemporal dementia, and late-life depression: A retrospective analysis. J Geriatr Psychiatry Neurol. 1997; 10: 67-74.
18. Frisoni GB, Pizzolato G, Bianchetti A, et al.: Single photon emission computed tomography with [99Tc]-HMPAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: Preliminary results. Acta Neurologica Scand. 1994; 89: 199-203.
19. Dunner DL: Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry. 1994; 55: 48-57.
20. Magnuson TM, Roccaforte WH, Wengel SP, et al.: Medication-induced dystonias in nine patients with dementia. J Neuropsychiatry Clin Neurosci. 2000; 12: 219-225.
21. Mega MS, Dinov ID, Lee L, et al.: Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2000; 12: 209-218.
22. Tanaka Y, Miyazaki M, Albert ML: Effects of increased cholinergic activity on naming in aphasia. Lancet. 1997; 350: 116-117.
23. Urrutia L, Read M, Swartz R, et al.: Differentiation of Alzheimer's disease, frontotemporal dementia, and parkinsonian dementias. In Facts and Research in Gerontology, 1996: Alzheimer's Disease. New York: Springer, 1996, pp. 7-16.
24. Pina Latorre M, Modrego P, et al.: Parkinsonism and Parkinson's disease associated with long-term administration of sertraline. J Clin Pharm Ther. 2001; 26: 111-112.